IL-6/gp130/STAT3 signaling also has an established role in the aggressive and metastatic phenotype of PDAC and constitutes one of the essential signaling cascades in pancreatic cancer initiation and progression (Lesina et al. 2014). Here, IL6 is linked to pancreatic neoplasm.